Prevalence, Characteristics, and Risk Factors of Moderate or High Hyperopia among Multiethnic Children 6 to 72 Months of Age: A Pooled Analysis of Individual Participant Data.


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
07 2019
Historique:
received: 07 12 2018
revised: 15 02 2019
accepted: 20 02 2019
pubmed: 2 3 2019
medline: 3 3 2020
entrez: 2 3 2019
Statut: ppublish

Résumé

To describe the prevalence, ocular characteristics, and associated risk factors of moderate to high hyperopia in early childhood. Pooled analysis of individual participant data from population-based studies. Six- to 72-month-old multiethnic children who participated in 4 population-based studies of pediatric eye diseases. The pooled studies conducted comparable parental interviews and ocular examinations including cycloplegic autorefraction. Presence of hyperopia was defined based on cycloplegic refractive error in the worse eye. Multivariate analyses were performed to evaluate the association of potential risk factors with hyperopia risk. Prevalence and odds ratios of moderate to high hyperopia (≥4.0 diopters [D]). Cycloplegic refraction was completed in 15 051 children 6 to 72 months of age. Among these children, the overall prevalence of moderate to high hyperopia (≥4.0 D) in the worse eye was 3.2% (95% confidence interval, 2.9%-3.5%), accounting for 15.6% of all hyperopia (≥2.0 D). Among children with moderate to high hyperopia, both eyes were affected in 64.4%, 28.9% showed spherical anisometropia of 1.0 D or more, and 19.5% showed astigmatism of 1.5 D or more. Among 36- to 72-month-old children with moderate to high hyperopia, 17.6% wore glasses. Prevalence of moderate to high hyperopia was slightly less in 12- to 23-month-old children and was relatively stable in children 24 months of age and older. Non-Hispanic and Hispanic white race and ethnicity, family history of strabismus, maternal smoking during pregnancy, and being a participant in the United States studies were associated with a higher risk of moderate to high hyperopia (P < 0.05). By assembling similarly designed studies, our consortium provided robust estimates of the prevalence of moderate to high hyperopia in the general population and showed that in 6- to 72-month-old children, moderate to high hyperopia is not uncommon and its prevalence does not decrease with age. Risk factors for moderate to high hyperopia differ from those for low to moderate hyperopia (2.0-<4.0 D) in preschool children, with family history of strabismus and maternal smoking during pregnancy more strongly associated with moderate to high hyperopia than low to moderate hyperopia.

Identifiants

pubmed: 30822446
pii: S0161-6420(18)33220-2
doi: 10.1016/j.ophtha.2019.02.021
pmc: PMC6589395
mid: NIHMS1522680
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

989-999

Subventions

Organisme : NEI NIH HHS
ID : R21 EY025313
Pays : United States

Informations de copyright

Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Références

J Optom. 2016 Jan-Mar;9(1):13-21
pubmed: 26564446
Ophthalmic Epidemiol. 2006 Aug;13(4):253-62
pubmed: 16877284
Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1348-55
pubmed: 19933197
JAMA Pediatr. 2015 Feb;169(2):177-82
pubmed: 25546699
Lancet Glob Health. 2018 Jul;6(7):e769-e776
pubmed: 29859815
Br J Ophthalmol. 1985 Nov;69(11):851-3
pubmed: 3904821
Ophthalmology. 2016 Apr;123(4):676-8
pubmed: 27012695
JAMA Ophthalmol. 2017 Sep 1;135(9):947-953
pubmed: 28796851
Ophthalmic Physiol Opt. 2009 Jul;29(4):422-6
pubmed: 19523087
Eye (Lond). 1996;10 ( Pt 2):189-98
pubmed: 8776448
BMC Ophthalmol. 2014 Dec 23;14:163
pubmed: 25539893
Invest Ophthalmol Vis Sci. 2013 Jul 24;54(7):4941-55
pubmed: 23883788
Ophthalmology. 2011 Nov;118(11):2262-73
pubmed: 21856014
J Curr Ophthalmol. 2017 Sep 27;30(1):3-22
pubmed: 29564404
Optom Vis Sci. 2009 Aug;86(8):918-35
pubmed: 19650241
Eye (Lond). 2010 May;24(5):875-80
pubmed: 19745838
Ophthalmology. 2013 Oct;120(10):2109-16
pubmed: 23953098
Ophthalmology. 2009 Apr;116(4):739-46, 746.e1-4
pubmed: 19243832
Zebrafish. 2007 Spring;4(1):59-68
pubmed: 18041943
Ophthalmology. 2019 Jun;126(6):876-887
pubmed: 30615896
Br J Ophthalmol. 1990 Mar;74(3):158-9
pubmed: 2182103
Pediatr Neurol. 2015 Aug;53(2):146-50
pubmed: 26096619
Ophthalmology. 2011 Nov;118(11):2251-61
pubmed: 21856012
Arch Ophthalmol. 2008 Feb;126(2):252-8; quiz 161
pubmed: 18268218
Am J Epidemiol. 2001 Oct 15;154(8):694-701
pubmed: 11590081
Optom Vis Sci. 2014 Apr;91(4):383-9
pubmed: 24637486
Mol Vis. 2009;15:181-6
pubmed: 19169412
Optom Vis Sci. 2007 Feb;84(2):110-4
pubmed: 17299340
Am J Epidemiol. 1995 Dec 15;142(12):1255-64
pubmed: 7503045
Cochrane Database Syst Rev. 2014 Aug 18;(8):CD007738
pubmed: 25133974
Ophthalmology. 2016 Apr;123(4):681-9
pubmed: 26826748
Ophthalmology. 2011 Oct;118(10):1966-73
pubmed: 21856013
Am J Ophthalmol. 2016 Oct;170:143-152
pubmed: 27477769
Eur J Epidemiol. 2005;20(4):345-50
pubmed: 15971507
BMJ Open. 2018 Jun 12;8(6):e021277
pubmed: 29895654
Ophthalmology. 2011 Aug;118(8):1495-500
pubmed: 21529955
Am J Ophthalmol. 2013 Jul;156(1):190-4
pubmed: 23628351
Strabismus. 2004 Dec;12(4):227-45
pubmed: 15545141
Arch Pediatr Adolesc Med. 2010 Mar;164(3):250-7
pubmed: 20194258
Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4277-87
pubmed: 17003416

Auteurs

Xuejuan Jiang (X)

USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine of the University of Southern California, Los Angeles, California; Department of Preventive Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California. Electronic address: xuejuanj@usc.edu.

Kristina Tarczy-Hornoch (K)

Department of Ophthalmology, University of Washington, Seattle, Washington; Department of Ophthalmology, Seattle Children's Hospital, Seattle, Washington.

Douglas Stram (D)

Department of Preventive Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California.

Joanne Katz (J)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

David S Friedman (DS)

Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.

James M Tielsch (JM)

Department of Global Health, Milken Institute School of Public Health, George Washington University, Washington, DC.

Saiko Matsumura (S)

Singapore Eye Research Institute, Singapore, Republic of Singapore.

Seang-Mei Saw (SM)

Singapore Eye Research Institute, Singapore, Republic of Singapore; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Republic of Singapore.

Paul Mitchell (P)

Centre for Vision Research, Westmead Institute, Sydney, Australia.

Kathryn A Rose (KA)

Discipline of Orthoptics, Graduate School of Health, University of Technology Sydney, Ultimo, Australia.

Susan A Cotter (SA)

Southern California College of Optometry, Marshall B. Ketchum University, Fullerton, California.

Rohit Varma (R)

Southern California Eyecare and Vision Research Institute, CHA Medical Group PC, Hollywood Presbyterian Medical Center, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH